GI
NUVB icon

GAMMA Investing’s Nuvation Bio NUVB Stock Holding History

GAMMA Investing’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.68K Buy
1,550
+1,343
+649% +$8.43K ﹤0.01% 3424
2026
Q2 		$1.18K Sell
207
-203
-50% -$992 ﹤0.01% 3843
2026
Q1 		$1.76K Sell
410
-406
-50% -$2.26K ﹤0.01% 3706
2025
Q4 		$7.31K Buy
+816
New +$5.05K ﹤0.01% 3118

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return
EWA
Emergent Wealth Advisors Williamsville, New York $191M AUM 17.3% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's NUVB Position: Q3 2026 in Review

GAMMA Investing increased its Nuvation Bio (NUVB) stake by 649% in Q3 2026, buying an estimated $8.43K and bringing the position to 1,550 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #3424.

GAMMA Investing first reported a position in NUVB in Q4 2025 and has held it in 4 quarters since. 13 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • GAMMA Investing held 1,550 shares of Nuvation Bio worth $8.68K as of Q3 2026.
  • GAMMA Investing bought 1,343 Nuvation Bio shares in Q3 2026, an estimated $8.43K.
  • Nuvation Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3424 holding.
  • GAMMA Investing first reported a position in Nuvation Bio in Q4 2025 and has held it in 4 quarters since.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.